levonorgestrel has been researched along with etonogestrel in 131 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.76) | 18.7374 |
| 1990's | 23 (17.56) | 18.2507 |
| 2000's | 34 (25.95) | 29.6817 |
| 2010's | 63 (48.09) | 24.3611 |
| 2020's | 10 (7.63) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Johansson, E; Odlind, V; Olsson, SE | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Juchem, M; Pollow, K | 1 |
| Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA | 1 |
| Croxatto, H; Diaz, S; Peralta, O | 1 |
| Coutinho, EM; Ladipo, O | 1 |
| Kuhnz, W; Schütt, B; Woloszczak, R | 1 |
| Fraser, IS; Markham, R; Peek, MJ | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Lippert, TH; Lorkowski, G; Mück, AO; Seeger, H; Teichmann, AT | 1 |
| Asplund, B; Coelingh Bennink, H; Mäkäräinen, L; Tuomivaara, L; van Beek, A | 1 |
| Bennink, HC; Egberg, N; Gunnervik, C; Hirvonen, E; Hulkko, S; Larsson-Cohn, U; van Beek, A | 1 |
| Bennink, HC; Mascarenhas, L; Newton, J; van Beek, A | 2 |
| Edwards, JE; Moore, A | 1 |
| Mascarenhas, L | 1 |
| Croxatto, HB; Mäkäräinen, L | 1 |
| Affandi, B | 1 |
| Urbancsek, J | 1 |
| Kaper, RF; Qian, SZ; Sang, GW; Zheng, HM; Zheng, SR | 1 |
| Affandi, B; Korver, T; Suherman, SK | 1 |
| Buicu, C; Gaspard, U; van den Brûle, F | 1 |
| Walling, M | 1 |
| Colau, JC | 1 |
| Busse, R; Herkert, O; Kuhl, H; Schini-Kerth, VB | 1 |
| Rissanen, P | 1 |
| Bennink, HJ; Biswas, A; Korver, T; Ratnam, SS; Viegas, OA | 1 |
| Biswas, A; Coeling Bennink, HJ; Korver, T; Ratnam, SS; Viegas, OA | 1 |
| Darney, PD; Meckstroth, KR | 1 |
| Harwood, B; Mishell, DR | 1 |
| Tumolo, J | 1 |
| Meirik, O | 1 |
| Keder, LM | 1 |
| Mascarenhas, L; Varma, R | 1 |
| Du, MK; Yao, XY | 1 |
| Biswas, A; Roy, AC; Viegas, OA | 1 |
| Cohen, EB; Rossen, NN | 1 |
| Kamischke, A; Nieschlag, E; Zitzmann, M | 1 |
| Dieben, TO; Klimscheffskij, R; Tuppurainen, M; Venhola, M | 1 |
| Biswas, A; Biswas, S; Viegas, OA | 1 |
| Levine, JP | 1 |
| Guest, JF; Varney, SJ | 1 |
| Shulman, LP | 1 |
| Bray, JA; Bray, JD; Brown, EL; Ghatge, R; Horwitz, KB; Jacobsen, BM; Jelinsky, S; Lyttle, CR; Richer, JK; Saraf, K; Tunkey, C; Winneker, RC | 1 |
| Bahamondes, L; Dos Santos Fernandes, AM; Espejo-Arce, X; Lui-Filho, JF; Monteiro-Dantas, C; Perrotti, M; Petta, CA | 1 |
| Cagiano, R; Sabatini, R | 1 |
| Fraser, IS; Kaitu'u-Lino, TJ; Morison, NB; Salamonsen, LA; Zhang, J | 1 |
| Al-Jefout, M; Fraser, IS; Palmer, J | 1 |
| Shulman, LP; Simon, M | 1 |
| Cowan, F; French, R; Power, J | 1 |
| Mavranezouli, I | 1 |
| de Vernejoul, MC; Sarfati, J | 1 |
| Bonnema, R; McNamara, MC; Spencer, AL | 1 |
| Stephenson, V | 1 |
| Freeman, S; Shulman, LP | 1 |
| Burke, AE; McDonald-Mosley, R | 1 |
| Weisberg, E | 1 |
| Handasyde, KA; Hynes, EF; Renfree, MB; Shaw, G | 1 |
| Dallay, D; Hanisch, JU; Inki, P; Omokanye, S; Short, M | 1 |
| Randel, A | 1 |
| Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
| Basha, M; Burrows, LJ; Goldstein, AT | 1 |
| Ali, M; Brache, V; Culwell, K; Habib, NA; Jackson, E; Meirik, O; Orawan, K; Ortayli, N; Schmidt, J | 1 |
| Bender, NM; Mishell, DR; Montoro, M; Najera, SO; Segall-Gutierrez, P; Stanczyk, FZ | 1 |
| Bateson, D; Briggs, P; McNamee, K | 1 |
| Allsworth, JE; Madden, T; Peipert, JF; Secura, GM; Vickery, Z; Zhao, Q | 1 |
| Amaral, E; Bahamondes, L; Bahamondes, MV; Magalhães, A; Mishell, DR; Modesto, W; Pinto e Silva, JL; Tilley, IB | 1 |
| Black, KI; Mwalwanda, CS | 1 |
| Matthews, CM; Prescott, GM | 1 |
| Bateson, D; McGeechan, K; Mohapatra, L; Weisberg, E | 1 |
| Dallay, D; Inki, P; Omokanye, S; Short, M; Stauch, K | 1 |
| Hel, Z; Huijbregts, RP; Michel, KG | 1 |
| Bahamondes, L; Bahamondes, MV; Modesto, W | 1 |
| Anderson, RA; Chao, J; Page, ST | 1 |
| Micks, E; Prager, S | 1 |
| Amies Oelschlager, AM; Debiec, KE; Mantrala, MD; Micks, EA; Nizamic, T; Prager, SW | 1 |
| Schreiber, CA; Sober, S | 1 |
| Buckel, CM; Madden, T; McNicholas, C; Mullersman, J; Peipert, JF; Secura, GM; Zhao, Q | 1 |
| Hathaway, M; Torres, L; Vollett-Krech, J; Wohltjen, H | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Berenson, AB; Hirth, JM; Tan, A | 1 |
| Maddipati, R; McNicholas, C; Peipert, JF; Swor, E; Zhao, Q | 1 |
| Chen, M; Gallo, MF; Grey, TW; Lopez, LM; Stuebe, AM; Truitt, ST | 1 |
| Diedrich, JT; Drey, EA; Harper, CC; Sokoloff, A; Steinauer, JE; Upadhyay, UD | 1 |
| Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
| Ali, M; Bahamondes, L; Brache, V; Habib, N; Landoulsi, S; Meirik, O | 1 |
| Kovács-Kiss, D; Szabó, P; Zelkó, R | 1 |
| Apter, D; Briggs, P; Gemzell-Danielsson, K; Grunert, J; Lukkari-Lax, E; Rybowski, S; Tuppurainen, M | 1 |
| Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
| Skjeldestad, FE; Øvre-Eide, V | 1 |
| Benagiano, G; Bianchi, P; Brosens, I; Gordts, S; Guo, SW; Petraglia, F; Puttemans, P | 1 |
| Akin, A; Ali, M; Bahamondes, L; Brache, V; Habib, N; Hubacher, D; Landoulsi, S | 1 |
| Curtis, KM; Jatlaoui, TC; Riley, HEM | 1 |
| Goel, N; Priya, K; Rajaram, S | 1 |
| Madden, T; Omvig, K; Peipert, JF; Silva Dos Santos, PN | 1 |
| McNicholas, C; Peipert, JF; Swor, E; Wan, L | 1 |
| Gawron, LM; Law, A; Lynen, R; Sanders, JN; Turok, DK; Wen, L | 1 |
| Ali, M; Bahamondes, L; Bent Landoulsi, S | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Castillo Cañadas, AM; García Santos, F; Gómez García, MT; González de Merlo, G; González Mirasol, E; López Del Cerro, E; Serrano Diana, C | 1 |
| Banda, C; Chagomerana, M; Lemani, C; Nkambule, J; Talama, G; Tang, JH; Zgambo, W | 1 |
| Ali, M; Bahamondes, L; Brache, V; Habib, N | 1 |
| Goldstuck, ND; Le, HP | 1 |
| Ahmed, G; Lara, J; Meece, FA; Nair, H; Nickisch, K; Pollok, NE; Santhamma, B; Shaked, Z; Tekmal, RR; Zhao, C | 1 |
| Chen, L; Hu, J; Huang, Y; Wu, J; Zou, Y | 1 |
| Lavelanet, A; Thaxton, L | 1 |
| Bahamondes, L; Eloy, L; Margatho, D; Mota Carvalho, N | 1 |
| Bahamondes, L; Benetti-Pinto, CL; Carvalho, N; Cursino, K; Margatho, D | 1 |
| Baiamonte, L; Drobnis, EZ; Hope, TJ; Huang, L; Li, L; Mills, M; Quayle, AJ; Schust, DJ; Stark, M; Tu, J; Wang, W; Zhou, J | 1 |
| Brandão, ER | 1 |
| Allen, RH; Cohen, KE; Has, P; Matteson, KA | 1 |
| Akers, J; Augustine, MS; Buckner, LR; Drobnis, EZ; Hope, TJ; Mott, PD; Quayle, AJ; Rogers, LK; Schust, DJ | 1 |
| Bola-Oyebamiji, SB; Okunola, TO; Sowemimo, O | 1 |
| Baeten, JM; Blue, SW; Erikson, DW; Kelly, EJ; Kim, CJ; Kourtis, AP; Lingappa, JR; Mugo, N; Nanda, K; Patel, RC; Scarsi, KK; Stalter, RM; Tamraz, B; Thomas, KK | 1 |
| Gawron, LM; Gero, A; Kushner, KL; Sanders, JN; Turok, DK | 1 |
| Bahamondes, L; Carvalho, NM; Margatho, D | 1 |
| Bryson, AE; Cabral, HJ; Coles, MS | 1 |
| Crespi, S; Fabron, C; Farge, G; Lévy-Bachelot, L; Linet, T; Robert, J; Yang, JZ | 1 |
| McQuillan, SK; Rosenthal, MA | 1 |
| Brito, MB; da Silva, SBL; Maron, CC; Pinheiro, MSA; Trigo, ACM | 1 |
| Cheng, L; Nie, LK; Zhang, PH; Zou, HL | 1 |
| Gibson, DM; Ko, PJ; Milad, MA; Radulovic, LL | 1 |
| Byakika-Kibwika, P; Chappell, CA; Fletcher, CV; Jeppson, J; Kaboggoza, J; Kyohairwe, I; Lamorde, M; Mbabazi, L; Musaazi, J; Nakalema, S; Nakijoba, R; Nassiwa, S; Pham, M; Scarsi, KK; Siccardi, M; Walimbwa, SI; Winchester, L | 1 |
| Badda, M; Castillo, S; Catarino, R; Gezer-Dickschat, S; Lombardi Fäh, V; Thieringer, F; Tschudin, S; Viviano, M; Yaron, M | 1 |
33 review(s) available for levonorgestrel and etonogestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Subdermal contraceptive implants.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Norprogesterones; Ovulation; Progesterone | 1995 |
Implanon. A review of clinical studies.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Dysmenorrhea; Female; Humans; Hypertension; Levonorgestrel; Research Design; Vinyl Compounds; Weight Gain | 1999 |
Insertion and removal of Implanon.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Progesterone Congeners; Randomized Controlled Trials as Topic; Vinyl Compounds | 1998 |
The pharmacodynamics and efficacy of Implanon. An overview of the data.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptive Agents, Female; Desogestrel; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovary; Ovulation; Progesterone; Progesterone Congeners; Radioimmunoassay; Randomized Controlled Trials as Topic; Ultrasonography; Vinyl Compounds | 1998 |
An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Desogestrel; Dysmenorrhea; Female; Hemoglobins; Humans; Levonorgestrel; Longitudinal Studies; Medical Records; Menstruation Disturbances; Patient Dropouts; Progesterone Congeners; Randomized Controlled Trials as Topic; Vinyl Compounds | 1998 |
An integrated analysis of nonmenstrual adverse events with Implanon.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Headache; Humans; Levonorgestrel; Medical Records; Pain; Patient Dropouts; Progesterone Congeners; Vinyl Compounds; Weight Gain | 1998 |
[New forms of hormonal contraception].
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnenes; Vinyl Compounds | 2000 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Implant contraception.
Topics: Cervix Mucus; Clinical Trials as Topic; Contraceptive Agents, Female; Counseling; Desogestrel; Drug Implants; Endometrium; Female; Humans; Levonorgestrel; Megestrol; Norprogesterones; Ovulation; Patient Satisfaction; Pregnancy; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Vinyl Compounds | 2001 |
Contraceptive vaginal rings.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estradiol; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norprogesterones; Patient Acceptance of Health Care; Progesterone; Progestins; Vinyl Compounds | 2001 |
Use of progestins in male contraception.
Topics: Asian People; Contraception; Cyproterone Acetate; Desogestrel; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nandrolone; Progestins; Steroids; Testosterone; Time Factors; White People | 2003 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
Advances in female hormonal contraception: current alternatives to oral regimens.
Topics: Contraceptive Agents, Female; Desogestrel; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone | 2003 |
Alternatives to oral regimens of contraception.
Topics: Administration, Cutaneous; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Desogestrel; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Levonorgestrel; Male; Progestins; Sterilization, Tubal; Treatment Outcome; Vasectomy | 2007 |
Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Randomized Controlled Trials as Topic | 2007 |
Impact of combined and progestogen-only contraceptives on bone mineral density.
Topics: Bone Density; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Therapy, Combination; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menarche; Osteoporosis; Progesterone | 2009 |
Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
Topics: Adult; Clinical Trials as Topic; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Counseling; Desogestrel; Evidence-Based Medicine; Family Planning Services; Family Practice; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Levonorgestrel; Medroxyprogesterone Acetate; Ovulation Inhibition; Practice Guidelines as Topic; Pregnancy; Risk Factors; Women's Health; World Health Organization | 2009 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
The effects of hormonal contraceptives on female sexuality: a review.
Topics: Acne Vulgaris; Cervix Mucus; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; History, 20th Century; Humans; Levonorgestrel; Libido; Medroxyprogesterone Acetate; Progesterone Congeners; Sex Hormone-Binding Globulin; Sexuality; Vulva; Vulvodynia | 2012 |
Immediate post-partum initiation of intrauterine contraception and implants: a review of the safety and guidelines for use.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Postpartum Period; Practice Guidelines as Topic; Pregnancy | 2013 |
Long-acting reversible contraception: a review in special populations.
Topics: Age Factors; Animals; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Risk Factors; Sexually Transmitted Diseases | 2014 |
Male contraception.
Topics: Adamantane; Administration, Cutaneous; Androgens; Animals; Antispermatogenic Agents; Azoospermia; Clinical Trials as Topic; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Estrenes; Evidence-Based Medicine; Gels; Humans; Injections, Intramuscular; Levonorgestrel; Male; Oligospermia; Progestins; Sperm Count; Testosterone; Vasectomy | 2014 |
Plan A: postabortion contraception.
Topics: Abortion, Induced; Aftercare; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Counseling; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Sterilization, Tubal | 2014 |
Postpartum contraception.
Topics: Amenorrhea; Birth Intervals; Breast Feeding; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Sterilization, Tubal; Venous Thromboembolism | 2014 |
Increasing LARC utilization: any woman, any place, any time.
Topics: Attitude of Health Personnel; Contraceptive Agents, Female; Desogestrel; Drug Implants; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progestins | 2014 |
Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Topics: Breast Feeding; Child Development; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Infant; Lactation; Levonorgestrel; Milk, Human; Progestins; Randomized Controlled Trials as Topic | 2015 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
[Development possibilities of hormone-containing implants for gynecological applications: A review].
Topics: Animals; Contraceptive Agents, Female; Desogestrel; Estradiol; Female; Humans; Infusion Pumps, Implantable; Levonorgestrel; Norprogesterones | 2015 |
Pharmacologic treatment of the ovarian endometrioma.
Topics: Contraceptives, Oral; Desogestrel; Endometriosis; Female; Humans; Levonorgestrel | 2016 |
The safety of intrauterine devices among young women: a systematic review.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Randomized Controlled Trials as Topic; Risk Assessment; Young Adult | 2017 |
Delivery of progestins via the subdermal versus the intrauterine route: comparison of the pharmacology and clinical outcomes.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Pregnancy; Progestins | 2018 |
Systematic review of efficacy with extending contraceptive implant duration.
Topics: Adult; Case-Control Studies; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Progestins; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors | 2019 |
28 trial(s) available for levonorgestrel and etonogestrel
| Article | Year |
|---|---|
Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Ovarian Follicle; Progesterone; Progesterone Congeners; Prospective Studies; Sex Hormone-Binding Globulin; Time Factors; Vinyl Compounds | 1998 |
Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Female; Hemostasis; Humans; Levonorgestrel; Liver; Liver Function Tests; Progesterone Congeners; Prospective Studies; Vinyl Compounds | 1998 |
A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
Topics: Adolescent; Adult; Cervix Uteri; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Levonorgestrel; Prospective Studies; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears; Vinyl Compounds | 1998 |
Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Contraceptive Agents, Female; Coronary Disease; Desogestrel; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Risk Factors; Socioeconomic Factors; United Kingdom; Vinyl Compounds | 1998 |
A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Desogestrel; Female; Hemoglobins; Humans; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Uterine Hemorrhage; Vinyl Compounds | 1999 |
The effects of Implanon on lipid metabolism in comparison with Norplant.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Lipids; Time Factors; Vinyl Compounds | 1999 |
Effect of Implanon use on selected parameters of thyroid and adrenal function.
Topics: Adrenal Cortex; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Hydrocortisone; Levonorgestrel; Longitudinal Studies; Random Allocation; Sex Hormone-Binding Globulin; Thyroid Gland; Thyroid Hormones; Time Factors; Vinyl Compounds | 2000 |
Implanon contraceptive implants: effects on carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; Contraceptive Agents, Female; Desogestrel; Drug Implants; Fasting; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Kinetics; Levonorgestrel; Vinyl Compounds | 2001 |
[A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Uterine Hemorrhage | 2003 |
Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Implants; Humans; Levonorgestrel; Lipids; Triglycerides | 2003 |
The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Triglycerides | 2004 |
Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
Topics: Adult; Bilirubin; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Liver; Liver Function Tests; Progesterone Congeners; Treatment Outcome | 2004 |
A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants.
Topics: Absorptiometry, Photon; Adult; Bone Density; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Radius; Ulna | 2006 |
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage | 2006 |
A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
Topics: Adult; Chi-Square Distribution; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pain; Pruritus; Time Factors; Young Adult | 2013 |
Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth.
Topics: Adolescent; Adult; Breast Feeding; Child Development; Contraceptives, Oral, Combined; Desogestrel; Eating; Female; Humans; Infant; Infant Nutritional Physiological Phenomena; Intrauterine Devices, Copper; Levonorgestrel; Male; Milk, Human; Progestins; Young Adult | 2013 |
A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Topics: Adult; Body Mass Index; Contraception; Contraceptive Agents, Female; Counseling; Desogestrel; Female; Hemorrhage; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Weight Gain | 2014 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Outcome Assessment, Health Care; Pregnancy; Pregnancy, Unplanned; Time Factors; Young Adult | 2015 |
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Patient Satisfaction; Pregnancy; Pregnancy, Unplanned; Time Factors; Treatment Outcome; Young Adult | 2016 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Family Planning Services; Female; Humans; Levonorgestrel; Treatment Outcome; Young Adult | 2016 |
Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.
Topics: Adolescent; Adult; Cardiovascular Diseases; Chronic Pain; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Levonorgestrel; Medication Adherence; Middle Aged; Nausea; Patient Satisfaction; Pelvic Pain; Risk; Young Adult | 2016 |
A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Long-Acting Reversible Contraception; Weight Gain; Young Adult | 2018 |
Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
Topics: Adult; Biomarkers; Brazil; CA-125 Antigen; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometriosis; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Nerve Fibers; Pelvic Pain; Receptors, IgE; Treatment Outcome | 2018 |
Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Liberation; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain Management; Pelvic Pain | 2018 |
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
Topics: Adolescent; Adult; Brazil; CA-125 Antigen; Desogestrel; Drug Implants; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pain Measurement; Pelvic Pain; Young Adult | 2020 |
Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Time Factors | 2023 |
70 other study(ies) available for levonorgestrel and etonogestrel
| Article | Year |
|---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Clinical results with subcutaneous implants containing 3-keto desogestrel.
Topics: Binding, Competitive; Contraceptives, Oral, Combined; Desogestrel; Dihydrotestosterone; Drug Implants; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Hormonal; Cytoplasm; Desogestrel; Female; Humans; Kinetics; Levonorgestrel; Male; Norgestrel; Norpregnenes; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Transcortin; Uterus | 1990 |
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium | 1988 |
Contraceptive implants.
Topics: Adolescent; Adult; Consumer Behavior; Consumer Product Safety; Contraceptive Agents; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Megestrol; Menstruation Disturbances; Norpregnadienes | 1994 |
Influence of changes in the concentration of sex hormone-binding globulin in human serum on the protein binding of the contraceptive steroids levonorgestrel, 3-keto-desogestrel and gestodene.
Topics: Adult; Clinical Trials as Topic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Serum Albumin; Sex Hormone-Binding Globulin | 1994 |
The effects of natural and synthetic sex steroids on human decidual endothelial cell proliferation.
Topics: Capillaries; Cell Division; Cells, Cultured; Decidua; Desogestrel; Endothelium, Vascular; Estradiol; Female; Fluorescent Antibody Technique, Indirect; Gonadal Steroid Hormones; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progesterone | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles.
Topics: Aorta; Calcium; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; Muscle, Smooth, Vascular; Norpregnenes; Progesterone Congeners | 1996 |
Development of contraceptive implants.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Evaluation; Drug Implants; Humans; Levonorgestrel; United Kingdom; Vinyl Compounds | 2000 |
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Chloride; Chlormadinone Acetate; Cyclic AMP; Cyclic GMP; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; In Vitro Techniques; Jugular Veins; Levonorgestrel; Male; Norpregnenes; Potassium Chloride; Progesterone Congeners; Protein Kinase C; Rabbits; Rolipram; Tetradecanoylphorbol Acetate; Thionucleotides; Vasodilation | 2000 |
Economic analysis of long-term reversible contraceptives. Focus on Implanon.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progesterone Congeners; Vinyl Compounds | 2000 |
Update on contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Vinyl Compounds | 2000 |
Implantable contraceptives for women.
Topics: Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Levonorgestrel; Progesterone Congeners; Vinyl Compounds | 2002 |
New developments in contraception.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estradiol; Female; Forecasting; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Vinyl Compounds | 2002 |
Sonographic imaging in progestin users and future directions.
Topics: Desogestrel; Endometrium; Female; Humans; Levonorgestrel; Menstruation; Ovary; Progesterone Congeners; Ultrasonography; Uterus; Vagina; Vinyl Compounds | 2002 |
[Acne vulgaris in connection with the use of progestagens in a hormonal IUD or a subcutaneous implant].
Topics: Acne Vulgaris; Adult; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Isotretinoin; Levonorgestrel; Progestins | 2003 |
Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Delayed-Action Preparations; Desogestrel; Drug Administration Routes; Drug Implants; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Economic; Prospective Studies; Treatment Failure; United Kingdom | 2004 |
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
Topics: Alkaline Phosphatase; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Desogestrel; Dose-Response Relationship, Drug; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Levonorgestrel; Ligands; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Progesterone; Progestins; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transcription, Genetic | 2005 |
The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women.
Topics: Animals; Contraceptive Agents, Female; Decidua; Desogestrel; Electrophoresis, Polyacrylamide Gel; Endometrium; Estrogen Receptor alpha; Female; Immunohistochemistry; Intrauterine Devices, Medicated; Killer Cells, Natural; Levonorgestrel; Macrophages; Matrix Metalloproteinase 3; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Metrorrhagia; Mice; Mice, Inbred C57BL; Models, Animal; Neutrophils; Organ Size; Receptors, Progesterone; Time Factors; Uterus | 2007 |
Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis.
Topics: Adolescent; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain | 2007 |
The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Decision Trees; Desogestrel; Drug Administration Routes; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone; Models, Theoretical; Practice Guidelines as Topic; Sterilization, Tubal; Time Factors; United Kingdom | 2008 |
Migraine and risk of stroke. For contraception try IUDs ...
Topics: Brain Ischemia; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Migraine with Aura; Risk Factors; Stroke | 2009 |
Contraceptive implants.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Monitoring; Female; Humans; Levonorgestrel; Menorrhagia; Obesity; Pelvic Pain | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Levonorgestrel, not etonogestrel, provides contraception in free-ranging koalas.
Topics: Analysis of Variance; Animals; Animals, Wild; Contraception; Contraceptive Agents, Female; Desogestrel; Estrous Cycle; Female; Levonorgestrel; Phascolarctidae; Population Control; Pregnancy; Progesterone; Radioimmunoassay | 2010 |
ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices.
Topics: Abortion, Induced; Abortion, Spontaneous; Actinomyces; Antibiotic Prophylaxis; Bone Density; Breast Feeding; Cervix Uteri; Contraceptive Agents, Female; Copper; Desogestrel; Device Removal; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstrual Cycle; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Sexually Transmitted Diseases | 2011 |
Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Qualitative Research | 2012 |
Guidelines for the use of long-acting reversible contraceptives.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Practice Guidelines as Topic; Pregnancy | 2012 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |
Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
Topics: Adolescent; Adolescent Behavior; Adolescent Health Services; Confidentiality; Contraceptive Agents, Female; Desogestrel; Directive Counseling; Female; Humans; Informed Consent By Minors; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; United States | 2012 |
Effects of progestin-only long-acting contraception on metabolic markers in obese women.
Topics: Animals; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol, HDL; Contraceptive Agents, Female; Desogestrel; Fasting; Female; Insulin; Insulin Resistance; Insulin-Secreting Cells; Intrauterine Devices, Medicated; Levonorgestrel; Metabolic Syndrome; Obesity; Progestins; Prospective Studies; Waist Circumference | 2013 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |
Weight change at 12 months in users of three progestin-only contraceptive methods.
Topics: Adolescent; Adult; Black or African American; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Missouri; Progestins; Prospective Studies; Urban Health; Weight Gain; Young Adult | 2013 |
A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Topics: Adult; Age Factors; Amenorrhea; Australia; Contraception; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Longitudinal Studies; Marital Status; Metrorrhagia; Parity; Patient Satisfaction; Young Adult | 2014 |
Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
Topics: Adult; Contraception; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; France; Humans; Intrauterine Devices, Medicated; Ireland; Levonorgestrel; Longitudinal Studies; Middle Aged; Patient Acceptance of Health Care; Prospective Studies; Slovakia; United Kingdom; Young Adult | 2014 |
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Topics: Adult; Cells, Cultured; Contraceptive Agents, Female; Cytokines; Delayed-Action Preparations; Dendritic Cells; Desogestrel; Female; HIV-1; Humans; Imidazoles; Immune Tolerance; Levonorgestrel; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone Acetate; Norethindrone; Oligodeoxyribonucleotides; Progestins; Toll-Like Receptor 9; Toll-Like Receptors | 2014 |
Long acting reversible contraception in adolescents with cardiovascular conditions.
Topics: Adolescent; Cardiovascular Diseases; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Young Adult | 2014 |
Provision of no-cost, long-acting contraception and teenage pregnancy.
Topics: Abortion, Induced; Adolescent; Birth Rate; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Prospective Studies; United States; Young Adult | 2014 |
Complications and continuation rates associated with 2 types of long-acting contraception.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Compliance; Retrospective Studies; Subcutaneous Tissue; Young Adult | 2015 |
Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Time Factors; United States; United States Food and Drug Administration; Young Adult | 2015 |
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Topics: Abortion, Induced; Adolescent; Adult; Body Weight; Choice Behavior; Contraception; Contraceptive Agents, Female; Decision Making; Desogestrel; Drug Implants; Educational Status; Female; Humans; Intimate Partner Violence; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Racial Groups; Stress, Psychological; Young Adult | 2015 |
Use pattern for contraceptive implants in Norway.
Topics: Adolescent; Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Cross-Sectional Studies; Databases, Factual; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Middle Aged; Norway; Practice Patterns, Physicians'; Young Adult | 2016 |
Changes in body composition in women using long-acting reversible contraception.
Topics: Adult; Analysis of Variance; Body Composition; Body Mass Index; Body Weight; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Linear Models; Prospective Studies; Young Adult | 2017 |
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Time Factors; United States; United States Food and Drug Administration; Young Adult | 2017 |
Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Delivery of Health Care; Desogestrel; Drug Implants; Female; Hispanic or Latino; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Reimbursement Mechanisms; Retrospective Studies; Time Factors; Young Adult | 2017 |
Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Product Labeling; Randomized Controlled Trials as Topic; Time Factors; United States; United States Food and Drug Administration | 2017 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Levonorgestrel; Long-Acting Reversible Contraception; Menstruation; Retrospective Studies; Young Adult | 2018 |
Two-year contraceptive continuation rates among immediate postpartum implant users at a district hospital in Malawi: a prospective cohort study.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Long-Acting Reversible Contraception; Malawi; Postnatal Care; Prospective Studies; Young Adult | 2018 |
Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives.
Topics: Animals; Contraceptive Agents, Female; Desogestrel; Esters; Female; Injections, Subcutaneous; Levonorgestrel; Ovulation; Rats; Rats, Sprague-Dawley | 2018 |
Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Topics: Adenomyosis; Adult; China; Desogestrel; Dysmenorrhea; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Levonorgestrel; Luteinizing Hormone; Middle Aged; Uterus | 2018 |
Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.
Topics: Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Receptors, CCR5; Receptors, CXCR4; T-Lymphocytes; Young Adult | 2019 |
[Long-acting reversible contraception methods in the Brazilian Unified National Health System: the debate on women's (in)discipline].
Topics: Adolescent; Brazil; Contraception, Postcoital; Contraceptive Agents, Female; Desogestrel; Family Planning Services; Female; Humans; Levonorgestrel; Long-Acting Reversible Contraception; National Health Programs; Time Factors; Young Adult | 2019 |
An exploratory study of the perception of contraceptive safety and impact on lactation among postpartum nurses at Women and Infants Hospital in 2017.
Topics: Adult; Contraception; Contraceptive Agents, Female; Desogestrel; Female; Health Knowledge, Attitudes, Practice; Hospitals, Maternity; Humans; Intrauterine Devices; Lactation; Levonorgestrel; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Middle Aged; Nurses; Practice Patterns, Nurses'; Rhode Island; Young Adult | 2019 |
Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
Topics: Adolescent; Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Young Adult | 2019 |
Comparison of weight gain between levonorgestrel and etonogestrel implants after 12 months of insertion.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Prospective Studies; Time Factors | 2019 |
A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Drug Antagonism; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Linear Models; Nevirapine; Pharmacogenomic Testing; Uganda | 2019 |
Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Hormonal; Contraceptives, Postcoital; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Tests; Risk Assessment; Time Factors; Unsafe Sex; Young Adult | 2020 |
Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
Topics: Adolescent; Aftercare; Case-Control Studies; Contraception Behavior; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices; Levonorgestrel; Long-Acting Reversible Contraception; Office Visits; Patient Compliance; Retrospective Studies | 2021 |
Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Desogestrel; Drug Administration Routes; Female; France; Humans; Levonorgestrel; Long-Acting Reversible Contraception; Middle Aged; Models, Economic; Pregnancy; Young Adult | 2021 |
Adolescent contraception.
Topics: Adolescent; Bone Density; Canada; Contraception; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Sexually Transmitted Diseases | 2021 |
Female sexual function in women using LARC methods.
Topics: Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Desogestrel; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Quality of Life; Sexual Dysfunction, Physiological | 2022 |
Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports.
Topics: Adenomyosis; Desogestrel; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2022 |
Pharmacokinetics of levonorgestrel and etonogestrel in rat or minipig following intravenous, subcutaneous, or intradermal administration.
Topics: Animals; Contraceptive Agents; Desogestrel; Levonorgestrel; Rats; Rats, Sprague-Dawley; Swine; Swine, Miniature | 2022 |
Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy.
Topics: Contraceptive Agents; Darunavir; Female; HIV Infections; Humans; Levonorgestrel; Progestins; Rilpivirine; Ritonavir | 2022 |